Better Reimbursement Decision-Making Based on Expected Cost-Effectiveness- Using Value of Information Decision Analysis to Improve The Design and Efficacy of A Phase Iii Program for Erlotinib
Abstract
Authors
SC Mukherjee N Latimer P Richards RM Nixon PS Hall